| abstract |
The disclosure provides a phosphatidylinositol 3-kinase (PI3K) inhibitor of formula (J), or a pharmaceutically acceptable salt thereof, wherein n, m, R 1 , R 2 , and R 3 are , As defined herein. These compounds are useful for the treatment of conditions mediated by one or more PI3K isoforms, such as PI3Kδ. The present disclosure further provides pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, as well as to treat a condition mediated by one or more PI3K isoforms such as PI3Kδ. Methods of using these compounds and compositions are provided. |